ChipsThe story, in brief
Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs
3,500 NVIDIA Blackwell GPUs. That's what Roche just deployed across drug discovery, diagnostics, and manufacturing—scaling AI infrastructure across the entire pharma value chain.
The KeyNews take
Why it matters
Enterprise-scale AI infrastructure deployment signals how Fortune 500 companies are moving beyond pilots to systematic GPU buildouts across core business functions. This is compute capacity becoming a competitive moat in regulated industries.
The key facts
5 to know3,500+ NVIDIA Blackwell GPUs deployed globally
Deployment spans R&D, diagnostics, and manufacturing
Entire value chain integration
Published by NVIDIA (vendor source)
March 2026 — recent enterprise deployment
Go to the source
NVIDIA Blogblogs.nvidia.com
Publisher excerpt: Roche's new deployment spans more than 3,500 NVIDIA Blackwell GPUs across its worldwide operations and embedded across the entire value chain, massively scaling R&D productivity, next-generation diagnostics and manufacturing efficiencies.